4//SEC Filing
BENNETT C FRANK 4
Accession 0000874015-26-000017
CIK 0000874015other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:34 PM ET
Size
5.8 KB
Accession
0000874015-26-000017
Insider Transaction Report
Form 4
BENNETT C FRANK
EVP, Chief Scientific Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2026-01-02+19,350→ 19,350 totalExercise: $79.67From: 2027-01-02Exp: 2036-01-01→ Common Stock (19,350 underlying)
Footnotes (1)
- [F1]Grant on 01/02/2026 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2026. 25% of the shares subject to the option will vest and become exercisable on 01/02/2027. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001073387
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:34 PM ET
- Size
- 5.8 KB